Your browser doesn't support javascript.
loading
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
Singh, Navneet; Daly, Megan E; Ismaila, Nofisat.
Affiliation
  • Singh N; Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Daly ME; University of California Davis Comprehensive Cancer Center, Sacramento, CA.
  • Ismaila N; American Society of Clinical Oncology, Alexandria, VA.
J Clin Oncol ; 41(27): 4430-4432, 2023 09 20.
Article in En | MEDLINE | ID: mdl-37471673
ABSTRACT
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article